U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of the insulin for the treatment of the type 1 diabetes in the US has now almost doubled according to the statistics of last five years and that amount has underscored the national outcry which is actually over raising the prices of the drugs. The patient having the type 1 diabetes on the average basis according to the statistics of the year 2016, costs the annual insulin of $5,705 and the average of the estimate roughly to the half as per patient was about $2,864 per patient and these statistics are according to the reports presented in the year 2012. Overall these figures show that there is a high portion of the amount that have been paid by a patient for his health plans on the medications and they doesn’t reflect any of them to be paid at a later date.
The costs of the insulin have highly increased and this has become the major risk for the health of the diabetic patients. In the past some months, there have been a lot of anecdotal stories which have cropped up from the family members and also by the patients and the key thing which have been described in that is the rationing of the medications that really are lifesaving because they in a way couldn’t afford the expenses which are made for the insulin and which generally are out-of-pocket. There were also some protests been conducted as the consequences outside the headquarters of the insulin maker company?